Literature DB >> 14636586

Differential phosphorylation and subcellular localization of La RNPs associated with precursor tRNAs and translation-related mRNAs.

Robert V Intine1, Scott A Tenenbaum, Amy L Sakulich, Jack D Keene, Richard J Maraia.   

Abstract

The La protein facilitates the production of tRNAs in the nucleus and the translation of specific mRNAs in the cytoplasm. We report that human La that is phosphorylated on serine 366 (pLa) is nucleoplasmic and associated with precursor tRNAs and other nascent RNA polymerase III transcripts while nonphosphorylated (np)La is cytoplasmic and associated with a subset of mRNAs that contain 5'-terminal oligopyrimidine (5'TOP) motifs known to control protein synthesis. Thus, La ribonucleoproteins (RNP) exist in distinct states that differ in subcellular localization, serine 366 phosphorylation, and associated RNAs. These results are consistent with a model in which the relative concentrations of the La S366 isoforms in different subcellular compartments in conjunction with the relative concentrations of specific RNA ligands in these compartments determine the differential association of npLa and pLa with their respective classes of associated RNAs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636586     DOI: 10.1016/s1097-2765(03)00429-5

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  57 in total

1.  Nonphosphorylated human La antigen interacts with nucleolin at nucleolar sites involved in rRNA biogenesis.

Authors:  Robert V Intine; Miroslav Dundr; Alex Vassilev; Elena Schwartz; Yingmin Zhao; Yingxin Zhao; Melvin L Depamphilis; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

2.  Conservation of a masked nuclear export activity of La proteins and its effects on tRNA maturation.

Authors:  Mark A Bayfield; Trish E Kaiser; Robert V Intine; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2007-02-16       Impact factor: 4.272

3.  Plant-specific ribosome biogenesis factors in Arabidopsis thaliana with essential function in rRNA processing.

Authors:  Denise Palm; Deniz Streit; Thiruvenkadam Shanmugam; Benjamin L Weis; Maike Ruprecht; Stefan Simm; Enrico Schleiff
Journal:  Nucleic Acids Res       Date:  2019-02-28       Impact factor: 16.971

Review 4.  Nucleolar adaptation in human cancer.

Authors:  Leonard B Maggi; Jason D Weber
Journal:  Cancer Invest       Date:  2005       Impact factor: 2.176

5.  Human La is found at RNA polymerase III-transcribed genes in vivo.

Authors:  Jennifer A Fairley; Theodoros Kantidakis; Niall S Kenneth; Robert V Intine; Richard J Maraia; Robert J White
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 6.  Codon-biased translation can be regulated by wobble-base tRNA modification systems during cellular stress responses.

Authors:  Lauren Endres; Peter C Dedon; Thomas J Begley
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

7.  CK2 is responsible for phosphorylation of human La protein serine-366 and can modulate rpL37 5'-terminal oligopyrimidine mRNA metabolism.

Authors:  Elena I Schwartz; Robert V Intine; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 8.  Transcription termination by the eukaryotic RNA polymerase III.

Authors:  Aneeshkumar G Arimbasseri; Keshab Rijal; Richard J Maraia
Journal:  Biochim Biophys Acta       Date:  2012-10-23

9.  La autoantigen is necessary for optimal function of the poliovirus and hepatitis C virus internal ribosome entry site in vivo and in vitro.

Authors:  Mauro Costa-Mattioli; Yuri Svitkin; Nahum Sonenberg
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer.

Authors:  Robert Calaluce; Matthew M Gubin; J Wade Davis; Joseph D Magee; Jing Chen; Yuki Kuwano; Myriam Gorospe; Ulus Atasoy
Journal:  BMC Cancer       Date:  2010-04-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.